VCYT Veracyte Inc

USD 40.99 +0.10 ( +0.24)%
Icon

Veracyte Inc (VCYT) Stock Analysis and Price Targets

COMMON STOCK | Diagnostics & Research | NSD
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Hold

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 40.99

+0.10 (+0.24)%

USD 3.42B

0.74M

USD 37.50(-8.51%)

N/A

Icon

VCYT

Veracyte Inc (USD)
COMMON STOCK | NSD
USD 40.99
+0.10 ( +0.24)%
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Hold

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 3.42B

N/A

USD 40.99

Veracyte Inc (VCYT) Stock Forecast

Show ratings and price targets of :
USD 37.50
(-8.51%)

Based on the Veracyte Inc stock forecast from 8 analysts, the average analyst target price for Veracyte Inc is USD 37.50 over the next 12 months. Veracyte Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Veracyte Inc is Neutral, which is based on 4 positive signals and 4 negative signals. At the last closing, Veracyte Inc’s stock price was USD 40.99. Veracyte Inc’s stock price has changed by -5.40% over the past week, +3.54% over the past month and +44.99% over the last year.

No recent analyst target price found for Veracyte Inc
No recent average analyst rating found for Veracyte Inc

Company Overview Veracyte Inc

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Canc...Read More

https://www.veracyte.com

6000 Shoreline Court, South San Francisco, CA, United States, 94080

815

December

USD

USA

Adjusted Closing Price for Veracyte Inc (VCYT)

Loading...

Unadjusted Closing Price for Veracyte Inc (VCYT)

Loading...

Share Trading Volume for Veracyte Inc Shares

Loading...

Compare Performance of Veracyte Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for VCYT

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Veracyte Inc (Sector: Diagnostics & Research )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
IDXX
IDEXX Laboratories Inc +0.90 (+0.22%) USD35.79B 42.19 29.14

Frequently Asked Questions About Veracyte Inc (VCYT) Stock

Based on ratings from 8 analysts Veracyte Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Neutral. The stock has 7 buy, 2 sell and 1 hold ratings.

Unfortunately we do not have enough data on VCYT's stock to indicate if its a good dividend stock.

Based on targets from 8 analysts, the average taret price for VCYT is USD 37.50 over the next 12 months. The maximum analyst target price is USD 50 while the minimum anlayst target price is USD 26.

Unfortunately we do not have enough data on VCYT's stock to indicate if its overvalued.

The last closing price of VCYT's stock was USD 40.99.

The most recent market capitalization for VCYT is USD 3.42B.

Based on targets from 8 analysts, the average taret price for VCYT is projected at USD 37.50 over the next 12 months. This means that VCYT's stock price may go down by -8.51% over the next 12 months.

We can't find any ETFs which contains Veracyte Inc's stock.

As per our most recent records Veracyte Inc has 815 Employees.

Veracyte Inc's registered address is 6000 Shoreline Court, South San Francisco, CA, United States, 94080. You can get more information about it from Veracyte Inc's website at https://www.veracyte.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Frequently Asked Questions About Veracyte Inc (VCYT) Stock

Based on ratings from 8 analysts Veracyte Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Neutral. The stock has 7 buy, 2 sell and 1 hold ratings.

Unfortunately we do not have enough data on VCYT's stock to indicate if its a good dividend stock.

Based on targets from 8 analysts, the average taret price for VCYT is USD 37.50 over the next 12 months. The maximum analyst target price is USD 50 while the minimum anlayst target price is USD 26.

Unfortunately we do not have enough data on VCYT's stock to indicate if its overvalued.

The last closing price of VCYT's stock was USD 40.99.

The most recent market capitalization for VCYT is USD 3.42B.

Based on targets from 8 analysts, the average taret price for VCYT is projected at USD 37.50 over the next 12 months. This means that VCYT's stock price may go down by -8.51% over the next 12 months.

We can't find any ETFs which contains Veracyte Inc's stock.

As per our most recent records Veracyte Inc has 815 Employees.

Veracyte Inc's registered address is 6000 Shoreline Court, South San Francisco, CA, United States, 94080. You can get more information about it from Veracyte Inc's website at https://www.veracyte.com.
Loading...